Anskaffelser: Vaksiner mot hepatitt B

7 arkiverte anskaffelser

Vaksiner mot hepatitt B har blitt anskaffet av organisasjoner som Folkehelseinstituttet, Nasjonalt folkehelseinstitutt og Nasjonalt Folkehelseinstitutt (The Norwegian Institute of Public Health).
Historisk har leverandører innenfor dette området vært GlaxoSmithKline AS og MSD (Norge) AS.

Nyeste anskaffelser av vaksiner mot hepatitt B i Norge

2023-07-03   Hexavalent vaccine - a combination vaccine against diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (Folkehelseinstituttet)
The Norwegian Institute of Public Health would like to procure diphtheria, tetanus, whooping cough, polio, Haemophilus influenza type B, and hepatitis B combination vaccines (hexavalent vaccine) for babies in the Norwegian child vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD). The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the notice, and the tender documentation stipulates … Vis anskaffelsen »
2022-05-10   Hepatitis B vaccines (Folkehelseinstituttet)
The Norwegian Institute of Public Health would like to procure Hepatitis B vaccines for the national vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD). The aim of the procurement is to enter into a contract for the delivery of a vaccine against Hepatitis B for the Norwegian child vaccination programme. Vis anskaffelsen »
Nevnte leverandører: MSD (Norge) AS
2019-12-23   Hepatitis B Vaccines (Folkehelseinstituttet)
Folkehelseinstituttet [the Norwegian Institute of Public Health] would like to procure Hepatitis B vaccines for the national vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD). The procurement shall be implemented as an open tender contest in accordance with the Public Procurement Regulations' Parts 1 and 3. The procurement will be implemented electronically via the CTM-KGV portal (EU-Supply) and published on Doffin and TED. Prior to the … Vis anskaffelsen »
2019-04-16   Hexavalent Vaccine — A Combination Vaccine against Diphtheria, Tetanus, Whooping Cough, Polio, Hib and Hepatitis B (Folkehelseinstituttet)
The Norwegian Institute of Public Health shall enter into a contract for the purchase of a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (hexavalent vaccine), for the national vaccine programme. The tender contest is carried out on behalf of the Norwegian Institute of Public Health (HOD). Norway has had a hexavalent vaccine programme since 2016. The current contract expires 31.12.2019 and shall be replaced by a new contract subsequent to the tender … Vis anskaffelsen »
Nevnte leverandører: GlaxoSmithKline AS
2016-06-18   A combination vaccine against diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (The Norwegian Institute of Public Health)
The Norwegian Institute of Public Health shall enter into an agreement regarding the purchase of a combination vaccine for the diseases: diphtheria, whooping cough, tetanus, polio, Hib and hepatitis B (a 6 component vaccine), for the National Vaccine Programme. The 6 component vaccine shall replace the current 5 component vaccine (diphtheria, whooping cough, tetanus, polio and Hib) and partly vaccine against hepatitis B for defined risk groups. The procurement is carried out on behalf of the Norwegian … Vis anskaffelsen »
2015-04-24   A combination vaccine against diphtheria, tetanus, pertussis, polio, Hib and hepatitis B (Nasjonalt Folkehelseinstitutt (The Norwegian Institute of Public Health))
The Norwegian Institute of Public Health shall enter into an agreement regarding the purchase of a combination vaccine for the diseases diphtheria, tetanus, pertussis, polio, Hib and hepatitis B (a six component vaccine), for the National Vaccine Programme The six component vaccine shall replace the existing five component vaccine (diphtheria, tetanus, pertussis, polio and Hib). It shall also partly replace the vaccine against hepatitis B for defined risk groups. The six component vaccine is expected to … Vis anskaffelsen »
2014-09-18   Vaccines against Hepatitis B (Nasjonalt folkehelseinstitutt)
The Norwegian Institute of Public Health would like to procure vaccines against Hepatitis B for the national vaccination programme. In 2014 the Norwegian Institute of Public Health will procure 45 000 child doses (0-15 years) and 8 000 adult doses (16 or older) of the vaccine against Hepatitis B for use in the vaccination programme. The Norwegian Institute of Public Health expects that the consumption of the vaccination against Hepatitis B will stay relatively stable. The Norwegian Institute of Public … Vis anskaffelsen »
Relaterte søk 🔍
Oppdragsgivere: Folkehelseinstituttet Nasjonalt folkehelseinstitutt Nasjonalt Folkehelseinstitutt (The... The Norwegian Institute of Public Health
Leverandører: GlaxoSmithKline AS MSD (Norge) AS
Produkter/tjenester: Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner Vaksiner mot hepatitt B Vaksiner mot difteri, kikhoste og stivkrampe Vaksiner mot difteri og stivkrampe Poliovaksiner